Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × Hepatectomy × Clear all

NCT03801915 2023-03-21

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Phase 2 Completed

10 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma